A detailed history of Vanguard Group Inc transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Vanguard Group Inc holds 2,887,556 shares of WVE stock, worth $44.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,887,556
Previous 2,417,690 19.43%
Holding current value
$44.1 Million
Previous $12.1 Million 96.26%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$5.12 - $9.01 $2.41 Million - $4.23 Million
469,866 Added 19.43%
2,887,556 $23.7 Million
Q2 2024

Aug 13, 2024

BUY
$4.38 - $6.48 $2.56 Million - $3.78 Million
583,600 Added 31.82%
2,417,690 $12.1 Million
Q1 2024

May 10, 2024

BUY
$3.54 - $6.84 $1.85 Million - $3.57 Million
521,665 Added 39.75%
1,834,090 $11.3 Million
Q4 2023

Feb 14, 2024

BUY
$4.16 - $6.87 $540,063 - $891,884
129,823 Added 10.98%
1,312,425 $6.63 Million
Q3 2023

Nov 14, 2023

BUY
$3.56 - $5.75 $101,107 - $163,305
28,401 Added 2.46%
1,182,602 $6.8 Million
Q2 2023

Aug 14, 2023

BUY
$3.51 - $4.69 $825,169 - $1.1 Million
235,091 Added 25.58%
1,154,201 $4.2 Million
Q1 2023

May 15, 2023

SELL
$3.58 - $6.3 $80,378 - $141,447
-22,452 Reduced 2.38%
919,110 $3.98 Million
Q4 2022

Feb 10, 2023

BUY
$3.18 - $7.0 $239,132 - $526,393
75,199 Added 8.68%
941,562 $6.59 Million
Q3 2022

Nov 14, 2022

BUY
$2.37 - $4.28 $344,102 - $621,417
145,191 Added 20.13%
866,363 $3.13 Million
Q2 2022

Aug 12, 2022

SELL
$1.23 - $3.25 $223,459 - $590,440
-181,674 Reduced 20.12%
721,172 $2.34 Million
Q1 2022

May 13, 2022

BUY
$2.0 - $3.28 $11,638 - $19,086
5,819 Added 0.65%
902,846 $1.81 Million
Q4 2021

Feb 14, 2022

BUY
$3.14 - $5.15 $177,026 - $290,346
56,378 Added 6.71%
897,027 $2.82 Million
Q3 2021

Nov 12, 2021

BUY
$4.89 - $7.12 $274,832 - $400,165
56,203 Added 7.16%
840,649 $4.12 Million
Q2 2021

Aug 13, 2021

BUY
$5.65 - $7.47 $4.43 Million - $5.86 Million
784,446 New
784,446 $5.22 Million

Others Institutions Holding WVE

About Wave Life Sciences Ltd.


  • Ticker WVE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,820,096
  • Market Cap $1.33B
  • Description
  • Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...
More about WVE
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.